PreventionGenetics' Virtual 2020 Booth
Published on
Welcome to PreventionGenetics' Virtual ACMG 2020 Booth
Since many conferences understandably had to cancel their 2020 meetings due to COVID-19, PreventionGenetics' invites you to visit our virtual booth! It's not the same as getting to see and interact with our team in person but we hope you enjoy this online experience with us.
New Developments
|
Rapid PGxome
Getting results fast is important for managing acutely ill patients. At PreventionGenetics, we offer comprehensive genetic testing options that allow patients to receive the answers they need quickly. This includes our Rapid PGxome® test—whole exome sequencing (WES) test—and Neonatal Crisis (NICU) panel. Both tests have an expedited average turnaround time of 14 days.
|
Prenatal PGxome
PreventionGenetics is pleased to offer a full menu of prenatal genetic tests, including whole exome sequencing - Prenatal PGxome®. Because of the urgent nature of prenatal testing, we have expedited turnaround times, Prenatal PGxome results are reported within 14 days. Our prenatal testing is diagnostic and requires specific criteria for testing such as abnormal ultrasound findings or a known familial variant. For all prenatal tests, a signed Healthcare Provider’s Statement is required.
|
|
Exome-Wide CNV Analysis
We have demonstrated through our validation studies that CNV detection via exome sequencing is at least as sensitive and often more sensitive than CMA. This newer option (Exome-Wide CNV Analysis) provides the opportunity to bypass standard CMA testing and test patients for both sequencing variants and CNVs in a single test, leading to lower costs and reduced turnaround time.
Watch our webinar Chromosomal Microarray: Going, Going, Gone. |
Comprehensive Autism Spectrum Disorders and Intellectual Disability (ASD-ID) Genetic Testing
Autism Spectrum Disorders (ASDs) and Intellectual Disability (ID) are a heterogeneous group of neurodevelopmental disorders that are inherited in a multifactorial fashion. Heritability estimates range between 50-90% for ASDs and 15-50% for ID. With an extensive list of genes that are associated with ASD-ID phenotypes, PreventionGenetics’ ASD-ID comprehensive panel is the best alternative to whole exome sequencing. Through work with collaborators and frequent panel updates, the ASD-ID comprehensive panel includes genes at the forefront of autism and intellectual disability research.
|
Claim One of Our Care Packages
We would like to provide our clients a small token of our appreciation during this difficult time.
Sign up for a PreventionGenetics' Care Package
Our care package includes a couple comfort items (i.e. a pair of DNA-themed socks and a bag clip), a few essentials to help you work from the office or at home (i.e. a pen, notepad, and a webcam cover), and some information on recent updates at PreventionGenetics.
Recent Exhibit Presentations
Join Dr. Diane Allingham-Hawkins, Ph.D., FCCMG, FACMG, as she explains when a rapid genomic sequencing test is appropriate and discusses the clinical utility of rapid DNA sequencing in the prenatal and neonatal period.
Review all our recent webinars here.
Review Our Experts' Recent Poster Presentations
|
The Spectrum of DICER1 Variants Detected in a Clinical Diagnostic Laboratory |
Large Gene Conversion Events Are Rare in PKD1 Gene |
|
The Clinical Utility of Detecting Copy Number Variants via Next-Generation Sequencing |
Expanding the Prenatal Phenotype of IPEX Syndrome |
|
Top 99 Genetic Causes of Developmental Delay |
View past poster presentations here. |
Chat with Our Team
While you weren't able to talk with our team in person this year, we want you to know that the PreventionGenetics team can always be reached at support@preventiongenetics.com. We would still love to provide additional information on our comprehensive genetic test menu, set up demonstrations on our services (e.g. how to order a Custom Panel), or arrange a one-on-one digital discussion with an Account Representative.
| The health and safety of our employees and customers is our highest priority. We are focused on supporting our clients and their patients during this difficult time. If you have any questions or concerns, please contact us. Stay safe, and we look forward to seeing you soon. |